Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests. (Q54034073)

23 May 2018

title

Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests. (English)

1 reference

23 May 2018

0 references

2

Barry AL

1 reference

23 May 2018

Peter C. Fuchs

series ordinal

1

object named as

Fuchs PC

1 reference

23 May 2018

Steven D. Brown

series ordinal

3

object named as

Brown SD

1 reference

23 May 2018

publication date

1 September 2000

1 reference

23 May 2018

Diagnostic Microbiology and Infectious Disease

published in

1 reference

23 May 2018

volume

38

1 reference

23 May 2018

issue

1

1 reference

23 May 2018

page(s)

51-58

1 reference

23 May 2018

Susceptibility of penicillin-sensitive and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Effect of abscess milieu on bactericidal activity of LY146032 against staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Comparative activity of LY146032 against anaerobic cocci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Effects of reduced cation supplement recommendations (National Committee for Clinical Laboratory Standards) on daptomycin antistaphylococcal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Effect of protein binding of daptomycin on MIC and antibacterial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Daptomycin: a novel agent for Gram-positive infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900164-4

7 January 2021

10.1016/S0732-8893(00)00164-4

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018